安踏體育(02020.HK)曾挫8.4%低見130.2元 遭大股東折讓7.5%配股套現115.7億元
安踏體育(02020.HK)大股東安踏國際以每股131.48元(較昨天收市價折讓7.5%),配售公司8,800萬股,套現115.7億元,交易完成後,其持股量將由50.81%降至47.56%。
該股今早低開7%報132.2元,跌幅曾擴至8.4%,股價一舉失守50天、20天及10天線(130.5-137.33元),最低見130.2元獲承接,曾回升至134元,現造132.2元,急吐7%,為最傷藍籌,成交受配股上板帶動增至1.126億股,涉資148.34億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.